Stockreport

Passage Bio Announces Exercise of Underwriters’ Option to Purchase Additional Shares

Passage Bio, Inc.  (PASG) 
PDF PHILADELPHIA, March 09, 2020 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (Nasdaq: PASG), a genetic medicines company focused on developing transformative therapies for rare, [Read more]